By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Advanced Accelerator Applications  

20 Rue Diesel

  Saint Genis Pouilly  01630  France
Phone: 33-0-4-50-99-30-70 Fax: 33-0-4-50-99-30-71


SEARCH JOBS








Company News
Zevacor Molecular To Produce Somakit-TATE Doses For Advanced Accelerator Applications 1/26/2016 9:03:31 AM
Advanced Accelerator Applications Reports 37% Growth In Sales For The Third Quarter Of 2015 And 32% Growth In Sales For The First Nine Months Of 2015 12/10/2015 7:29:43 AM
Advanced Accelerator Applications Announces Positive Results From Phase 3 Study NETTER-1 Evaluating Lutathera In Patients With Advanced Midgut Neuroendocrine Tumors 9/28/2015 10:10:40 AM
Advanced Accelerator Applications Announces Pivotal Phase 3 NETTER-1 Study Of Lutathera In Patients With Midgut Neuro Endocrine Tumors Meets Primary Endpoint And Data Will Be Presented In Presidential Session At The European Cancer Congress 2015 9/16/2015 9:55:11 AM
Advanced Accelerator Applications Completes €23 Million Crossover Financing With U.S.-Based Institutions 6/23/2015 8:43:25 AM
Advanced Accelerator Applications Reports Over 24% Growth In Sales For The First Quarter Of 2015 6/15/2015 12:13:56 PM
Advanced Accelerator Applications Meeting On Tuesday 16 June 2015, 11.00am 6/1/2015 1:22:02 PM
Advanced Accelerator Applications Reports 29.8% Sales Growth In 2014 While Continuing To Show Significant Clinical Progress Across Both Therapeutic And Diagnostic Platforms 4/9/2015 9:01:46 AM
French Diagnostic Firm Advanced Accelerator Applications Withdraws $75 Million IPO 2/19/2015 6:38:34 AM
Advanced Accelerator Applications Fully Acquires Atreus Pharmaceuticals, Inc.; Enrolls First Patient In A Phase 1/2 Clinical Trial For Its Key Diagnostic Candidate Annexin V-128 In Rheumatoid Arthritis And Ankylosing Spondylitis 1/8/2015 10:40:26 AM
12
//-->